Explore how immune system activity, particularly calprotectin levels, may predict early cardiovascular disease risk.

Hevin reverses cognitive decline in mice by improving neuronal connections, without affecting amyloid plaque levels.

Targeted liposomes decorated with peptides enhance the efficacy and safety of antifungal treatments against drug-resistant ...

Footprints to Recovery, a leading provider of addiction and mental health services, is pleased to announce the launch of its new, private inpatient mental health treatment program at its Elgin, ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on new products for rare diseases, today announced a partnership with Qureight, a ...

Noted Vaccine Researcher and Leader Kate O'Brien Awarded Sabin's Gold Medal Physician Livancliff Mbianke of Cameroon Receives Rising Star Award ...

The new CatSper diagnostic test helps identify undetectable sperm defects, improving infertility treatment outcomes in men with normal semen analysis.

Embla today announced results from a 64-week real-world study presented at the European Congress on Obesity, tracking nearly 2,700 adults in a digital GLP-1 treatment program. The study found that ...

Veterans with depression face a 14% higher risk of heart failure, says a Vanderbilt-led study analyzing over 3.4 million U.S. veterans, urging better depression care.

The website and visualization provide a detailed state-by-state analysis of opioid-related laws, regulations, and guidance for K-12 schools to respond to opioid challenges. Key fe ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company developing innovative therapies for unmet medical needs, today announced compelling preclinical data for HT-KIT, its ...

MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today announced that the U.S. Food and Drug Administration ...